Purchase Order HHSN272201600125P
- Not listed
- This is a federal contract award to Miltenyi Biotec, Inc., a biotechnology company that provides specialized scientific instruments, reagents, and services to government agencies. The award, valued at $4,563.50, is for the acquisition of antibodies from Miltenyi Biotec. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and is a firm fixed-price purchase order with no set-aside designation. Miltenyi...
- This federal contract award to Miltenyi Biotec, Inc., a global biotechnology company, is a one-time maintenance purchase order valued at $3,425.00. The contract was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), and did not have a set-aside designation. Miltenyi Biotec is an experienced federal contractor, having previously received awards from various agencies including the NIH, Department of Veterans Affairs,...
- This federal contract award to Miltenyi Biotec, Inc., a global biotechnology company, was made by the National Institutes of Health (NIH). The $12,867 firm fixed-price purchase order covers the supply of Miltenyi antibodies, cell separation starter kits, and related consumables. Miltenyi Biotec has an extensive history as a prime contractor for numerous federal agencies, including the NIH, Department of Veterans Affairs, and Department of Defense, providing a range of specialized laboratory...
- This is a $8,379.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company, for the supply of biomaterials. The award is not designated as a set-aside contract. Miltenyi Biotec is a prime contractor that frequently supports federal biomedical research programs with its specialized cell separation, analysis, and processing technologies, including flow cytometers, cell sorters, and...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The $12,810 contract provides for the delivery of specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. Key deliverables include flow cytometers, cell sorters, tissue dissociators, automated cell...
- This federal contract award to Miltenyi Biotec, Inc. is a $5,400 firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is not set aside and has an ultimate completion date of May 15, 2013. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is valued at $4,058.00 and provides for the delivery of Miltenyi Biotec's dissociation kits, buffers, and antibodies. This award is not associated with a set-aside designation....
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The $10,594.50 firm fixed-price purchase order was awarded to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development. The contract requires Miltenyi Biotec to deliver various cell...
- This $6,929.75 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized instruments, reagents, and services for biomedical research and cell therapy development. The contract does not have a set-aside designation. Miltenyi Biotec is delivering a range of products and services to support NIAID's research programs, particularly in areas such as cancer,...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $8,347.50 firm-fixed-price purchase order contract to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer. The contract is for the delivery of GentleMACTM Tumor Dissociator Kits, T-Cell Isolation Kits, and related columns. This purchase order is not associated with a set-aside program. Miltenyi Biotec is an experienced federal contractor, having provided specialized laboratory equipment,...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The $6,671 firm-fixed-price purchase order is for the supply of ANTIBODIES. Miltenyi Biotec is an experienced federal contractor, having received numerous awards from agencies such as the NIH, Department of Veterans Affairs, Food and Drug Administration, Department of Defense, Centers for Disease Control and Prevention, and U.S. Department of Agriculture. The company provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. This award is not associated with a set-aside program. However, Miltenyi Biotec has received some COVID-19 research support contracts. The company also holds a $2.3 million single-award indefinite delivery contract (IDC) with the NIH Clinical Center to supply proprietary CliniMACS cell isolation reagents and consumables through September 2024, with options to extend to 2027. This sole-source contract ensures the availability of FDA-approved, clinical-grade reagents and supplies compatible with the NIH's existing CliniMACS instrumentation to support the Center's cell processing and manufacturing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Other Administrative Action | $81 | 11/24/15 | |
| Not listed | Not listed | $6.6k | 11/20/15 |